AIA Group »

Alnylam Pharmaceuticals shares owned by AIA Group

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by AIA Group from 13F filings

Historical chart of AIA Group investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by AIA Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by AIA Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.8M 15k 191.41
2023-09-30 $2.6M 15k 177.10
2023-06-30 $2.4M 13k 189.94
2023-03-31 $1.1M 5.7k 200.32
2022-12-31 $1.2M 5.0k 237.65
2022-09-30 $785k 3.9k 200.05
2022-06-30 $421k 2.9k 145.93